Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer
<p>Abstract</p> <p>Background</p> <p>Bisphosphonate therapy has been readily accepted as standard of care for individuals with bone metastases from breast cancer. In this study we determined whether the proportion of patients experiencing a skeletal related event (SRE)...
Main Authors: | Lih Anna, Segelov Eva, Liauw Winston, Dunleavy Ms Ruth, Links Matthew, Ward Robyn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/5/89 |
Similar Items
-
Age-related differences in persistence with bisphosphonates in women with metastatic breast cancer
by: L. Jacob, et al.
Published: (2016-06-01) -
Bisphosphonates Treatment in Metastatic Prostate Cancer
by: F. Berardinelli, et al.
Published: (2005-05-01) -
Adjuvant bisphosphonates in early breast cancer
by: Rathbone, Emma Jane
Published: (2018) -
A systematic review of the role of bisphosphonates in metastatic disease
by: J Ross, et al.
Published: (2004-02-01) -
Anti-tumour effects of bisphosphonates in breast cancer
by: Jagdev, Satinder P. K.
Published: (2004)